The artificial intelligence market continues to demonstrate remarkable flexibility in bypassing geopolitical barriers. While U.S. export controls formally block the supply of advanced technologies to China, OpenAI and Google have found an elegant legal workaround through Singapore. This city-state has transformed into a neutral hub where American labs and Chinese tech giants operate virtually within walking distance of each other.
The essence of the scheme is simple and elegant: U.S. restrictions target specific companies and geographic zones. Mainland China is under sanctions; Singapore is not. Meanwhile, Alibaba, Baidu, and Tencent have had significant operations in the region for years. A Singapore-registered subsidiary of a blacklisted company is formally considered a Singaporean organization—it pays local taxes, operates under local laws, and can enter into contracts that are unavailable to its parent structure in Shenzhen or Hangzhou.
How the Singapore channel works
Alibaba Cloud already offers OpenAI-compatible software interfaces through its Singapore infrastructure. This means developers on the Alibaba platform gain access to models architecturally identical to those OpenAI sells directly, but through an intermediary in Southeast Asia. Meanwhile, Microsoft uses its exclusive commercial rights to license OpenAI models, distributing them via Azure within China itself—something OpenAI is prohibited from doing.
The presence of American labs in Singapore is growing rapidly. OpenAI has already invested over 300 million Singapore dollars (approximately $234 million) in establishing its first applied AI lab outside the U.S., with a launch planned for 2026. Google DeepMind has opened a regional research center there. All three Chinese cloud providers have been expanding their presence for years, building data centers and hiring local engineers.
Investment risks and regulatory threat
For investors, the situation creates a paradoxical dynamic: U.S. policy both restricts and facilitates China's access to American AI—depending on which corporate structure is making the sales. Restrictions target companies, not the technologies themselves, so capabilities flow through the structure that is not on the list.
The main risk here is regulatory. Chip export controls started narrow but gradually expanded. If the U.S. Department of Commerce decides that selling models to Singaporean subsidiaries of blacklisted companies violates the spirit of the restrictions, the entire scheme could collapse overnight.
My expert assessment: This situation is a classic example of corporate interests outpacing government regulation. I expect that within the next 12-18 months, we will see either a tightening of U.S. rules to close this loophole or the legalization of such schemes through a system of special licenses. In any case, Singapore is cementing its status as the primary "gray" hub of the global AI industry, and investors should closely monitor the rhetoric of regulatory bodies.